Skip to main content
Oxford University Press - PMC COVID-19 Collection logoLink to Oxford University Press - PMC COVID-19 Collection
. 2020 Oct 17:aqaa207. doi: 10.1093/ajcp/aqaa207

Effects of Storage Temperature and Media/Buffer for SARS-CoV-2 Nucleic Acid Detection

Namhee Kim 1,2, Ahrin Kwon 1, Eun Youn Roh 1, Jong Hyun Yoon 1, Mi Seon Han 2,3, Sang-Won Park 2,4, Hyunwoong Park 1,2,, Sue Shin 1,2,2,
PMCID: PMC7665474  PMID: 33067995

Abstract

Objectives

The increase in the number of patients with coronavirus disease 2019 (COVID-19) has delayed real-time reverse transcription–quantitative polymerase chain reaction (RT-qPCR), requiring proper shipping and storage conditions, especially in hot weather. This study aims to assess how some conditions, such as storage period, temperature, media or buffer, and sample types, affect the results of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RT-qPCR.

Methods

SARS-CoV-2–positive specimens were collected from Boramae Medical Center for 2 months (from May to June 2020) and stored in different media or buffers at different temperatures.

Results

As a result of examining confirmed patient samples, RT-qPCR results were not significantly affected by 2°C to 8°C storage until after 7 days. When stored at 20°C to 22°C or above 35°C, the results were affected negatively even after 1 day. Higher storage temperatures resulted in a lower probability of detecting viral nucleic acids because of degradation. Samples stored in pH-controlled media or buffer were more stable than those stored in nonbuffer states.

Conclusions

These results emphasize the importance of storage temperature and media or buffer and performing RT-qPCR for SARS-CoV-2 nucleic acid detection as soon as possible after sample collection.

Keywords: SARS-CoV-2, COVID-19, Shipping and storage, Temperature, Media and buffer, Molecular diagnostics, Coronavirus


Key Points.

  • When stored at 2°C to 8°C, samples positive for severe acute respiratory syndrome coronavirus 2 in universal transport medium (UTM) or phosphate-buffered saline (PBS) showed no significant cycle threshold change by real-time reverse transcription–quantitative polymerase chain reaction for 7 days.

  • The higher the storage temperature, the faster the nucleic acids degrade, and viral RNA could not be amplified in the molecular test even 1 day after storage.

  • The virus and nucleic acid were more stable in the pH-controlled UTM or PBS than in the non–pH-controlled buffer.

Coronavirus disease 2019 (COVID-19), which was first reported in Wuhan, China, in late 2019, is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).1-3 On March 11, 2020, the World Health Organization declared this disease a pandemic.4 As of July 18, 2020, the global cumulative confirmed cases were approximately 13.8 million, with approximately 600,000 deaths (the United States recorded a cumulative 3.5 million confirmed cases and 130,000 deaths; Korea recorded a cumulative 13,000 confirmed cases and 300 deaths).5 By July 18, the number of daily confirmed cases was approximately 260,000 and increasing each day.5 However, if we could consider all unofficial numbers that could not be included because of a lack of adequate testing and treatment, the actual cumulative number of confirmed cases would be much higher.

The diagnostic workup of current active SARS-CoV-2 infection is based on molecular tests.6-8 Respiratory specimens are collected from suspected patients, nucleic acids are extracted, and real-time reverse transcription–quantitative polymerase chain reaction (RT-qPCR) is used for diagnosis. RT-qPCR, which is approved for emergency use, identifies 2 or more SARS-CoV-2 genes, the target genes are amplified, and the samples are interpreted as positive.6-8 RT-qPCR helps not only to diagnose patients but also to determine the direction of treatment and to predict disease progression. The cycle threshold (Ct) value of the test can also be used to infer the severity and infectivity of the patients.9-11 Another important aspect of RT-qPCR is that it is included in the criteria to release COVID-19 patients from isolation.6-8 To confirm the clearance of the virus and to allow discharge from isolation in most countries, the patient has to be clinically recovered and/or have 2 negative RT-PCR results on sequential samples collected at least 24 hours apart.6-8

General laboratory medicine guidance regarding shipping and storage recommends storing samples in a refrigerator (2°C-8°C) immediately after collection.12 Consequently, the US Centers for Disease Control and Prevention, the European Center for Disease Prevention and Control, and the Korea Centers for Disease Control and Prevention also recommend storage of SARS-CoV-2 specimens at 2°C to 8°C for up to 72 hours after collection.6-8 If a delay in testing or shipping is expected, specimens should be stored at −70°C or below.6-8 However, given exponentially increasing cases—in addition to insufficient medical staff, collection kits, refrigeration and freezing facilities, and test equipment—the results could be delayed. Inevitably, most samples have been collected at designated walk-thru and drive-thru screening centers (far from medical institutions),13,14 and it could be difficult to follow this guidance because of a lack of storage facilities. As countries located in the northern hemisphere entered summer and many countries, including the United States, were updating the maximum number of daily confirmed cases, the recommended shipping and storage temperature should be reconsidered. In this study, we aimed to determine how temperature and storage media influence the results of SARS-CoV-2 RT-qPCR.

Materials and Methods

Nucleic Acid Extraction and RT-qPCR

Nucleic acids from samples were extracted using the EMAG system (bioMérieux), and RT-qPCR was performed using the Standard M nCoV Real-Time Detection Kit (SD Biosensor). The analysis was conducted using the CFX96 Real-Time Detection System (Bio-Rad). The PCR included 40-cycle amplification, following the manufacturer’s instructions, and was interpreted as positive when both E and RdRp were amplified in fewer than 36 cycles (Ct ≤ 36). In this study, for simplicity, the analysis was based on RdRp alone.

Respiratory Samples in Universal Transport Medium vs Phosphate-Buffered Saline

A total of 132 SARS-CoV-2–positive respiratory specimens were collected from Boramae Medical Center for 2 months (from May to June 2020). When the 132 respiratory samples (76 were a combination of nasopharyngeal swabs [NPS] and oropharyngeal swabs [OPS], whereas the rest were sputum) were separated according to the Ct values of RdRp:, “Ct ≤ 10 cycle” for 12 of 132 (9.1%), “10 < Ct ≤ 20 cycle” for 46 of 132 (34.8%), “20 < Ct ≤ 30 cycle” for 58 of 132 (43.9%), and “30 < Ct ≤ 36 cycle” for 16 of 132 (12.1%).

Of the 132 samples, we selected 80 and divided them into 2 groups of 40; half were NPS or OPS contained in universal transport medium (UTM; Noble Bioscience), and the other half were sputum in phosphate-buffered saline (PBS). The distribution of RdRp Ct values in both groups was structured similarly to that of the total 132 positive samples. Distribution for the UTM group was as follows: “Ct ≤ 10 cycle” for 3 of 40 (7.5%), “10 < Ct ≤ 20 cycle” for 15 of 40 (37.5%), “20 < Ct ≤ 30 cycle” for 17 of 40 (42.5%), and “30 < Ct ≤ 36 cycle” for 5 of 40 (12.5%). Distribution for the PBS group was as follows: “Ct ≤ 10 cycle” for 4 of 40 (10.0%), “10 < Ct ≤ 20 cycle” for 13 of 40 (32.5%), “20 < Ct ≤ 30 cycle” for 18 of 40 (45.0), and “30 < Ct ≤ 36 cycle” for 5 of 40 (12.5%).

For the 80 selected samples, the first molecular test date was set as the reference date (D0), and the remaining sample after the first test was divided into 0.6-mL aliquots and placed in a refrigerator (2°C-8°C), at room temperature (20°C-22°C), and in an incubator at 35°C to 40°C. Next, sequential molecular tests were conducted 1 day (D1), 2 days (D2), and 1 week (D7) later with the stored samples to confirm serial Ct values according to storage temperature and storage length.

Statistical Analysis

The results of the 2 groups were compared using a Student t test. One-way ANOVA with post hoc Tukey analysis was used when comparing 3 groups. All statistical analyses were carried out using SPSS, version 26.0 (IBM Corp), and P < .05 was considered statistically significant.

Stability of Low Viral Load Samples

Additional experiments were conducted to determine how susceptible the viral nucleic acids were to hot weather, depending on the type of sample and media or buffer. Various samples containing a small amount of virus (RdRp Ct values ranged from >30 to ≤36) were selected; these were obtained from patients with confirmed COVID-19 admitted to Boramae Medical Center for 2 months (from May to June 2020). Finally, we chose 5 respiratory (NPS or OPS) samples in UTM, 5 respiratory (sputum) samples in PBS, 5 respiratory (sputum) samples in distilled water (DW), 5 stool samples in PBS, and 5 serum samples without media or buffer. Unfortunately, in the case of urine from patients with COVID-19, all samples were negative during the study; therefore, virus-positive urine samples could not be chosen. The selected samples were incubated at 35°C to 40°C, and then RT-qPCR analysis was performed at D1 and D2.

Quantitative Test

The EDX SARS-CoV-2 standard reference materials (Exact Diagnostics) were synthetic RNA transcripts containing genes of SARS-CoV-2, namely, E, N, Orf1ab, RdRp, and S. We diluted the materials at a ratio of 1:10 to generate 100,000, 10,000, 1,000, and 100 copies/mL, and RT-qPCR was repeated 5 times at each concentration.

Ethics

This study was certified as exempt by the Boramae Medical Center institutional review board (07-2020-037).

Results

There was no significant difference in qualitative positivity between the 2 media or buffer conditions (ie, UTM and PBS) when they were stored at 3 different temperatures and compared for 7 days (P = .921 [D0], P = .888 [D7] at 2°C-8°C, P = .836 [D7] at 20°C-22°C, and P = .807 [D7] at 35°C-40°C). However, RT-qPCR Ct values differed depending on the temperature Figure 1 and Figure 2. When stored at 2°C to 8°C, all 80 samples showed no significant change for 7 days (Figure 1A). When stored at 20°C to 22°C, 1 sample in UTM (D0, Ct = 34.17 → D2 and D7, no fluorescence signal) and 2 samples in PBS had a negative change (D0, Ct = 33.52 → D1, D2, and D7, no fluorescence signal; D0, Ct = 32.18 → D7, no fluorescence signal). Moreover, the mean RT-qPCR Ct values of the D7 group were significantly different from those of the D0 group (Figure 1B). When stored at 35°C to 40°C, the mean of RT-qPCR Ct values gradually and prominently increased as the storage time increased Figure 2. In addition, 3 samples in UTM (D0, Ct = 34.17 → D1, D2, and D7, no fluorescence signal; D0, Ct = 31.02 → D2 and D7, no fluorescence signal; D0, Ct = 32.85 → D7, no fluorescence signal) and 3 samples in PBS (D0, Ct = 32.18 → D1, D2, and D7, no florescence signal; D0, Ct = 32.87 → D1, D2, and D7, no florescence signal; D0, Ct = 33.52 → D7, no florescence signal) had a negative change. Furthermore, the mean RT-qPCR Ct values of the D2 and D7 groups were significantly different from those of D0 (Figure 1C).

Figure 1.

Figure 1

Distribution of the Ct value of SARS-CoV-2 RdRp respiratory samples in UTM or PBS. A, Storage at 2°C to 8°C for 7 days. B, Storage at 20°C to 22°C for 7 days. C, Storage at 35°C to 40°C for 7 days. The circles indicate Ct values of samples in UTM, and the x marks indicate Ct values of samples in PBS. Bars indicate the mean (SEM). Negative results (fluorescence signal not detected, not amplified by PCR) are included in the statistical calculations, calculated by substituting 40 (the maximum PCR cycle). *P < .01; **P < .001. T(36) indicates interpretation as positive, target cutoff Ct ≤ 36. Ct, cycle threshold; NS, not significantly different; PBS, phosphate-buffered saline; PCR, polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; UTM, universal transport medium.

Figure 2.

Figure 2

Seven-day follow-up of the Ct value of SARS-CoV-2 RdRp in UTM (n = 40) (A) and PBS (n = 40) (B). Bars indicate the mean (SEM). Negative results (fluorescence signal not detected, not amplified by PCR) are included in the statistical calculations, calculated by substituting 40 (the maximum PCR cycle). Ct, cycle threshold; PBS, phosphate-buffered saline; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; UTM, universal transport medium.

Five samples with low SARS-CoV-2 viral loads were selected and incubated at 35°C to 40°C for 2 days: group 1, respiratory samples, NPS/OPS in UTM; group 2, respiratory samples, sputum in PBS; group 3, respiratory samples, sputum in DW; group 4, stool samples in PBS; and group 5, serum only, no buffer. The results are shown in Figure 3. Regardless of the sample type, the viral samples stored in UTM or PBS were occasionally detected even after 2 days; however, when stored in DW or incubated with serum alone, the majority of samples had a negative change. In addition, we obtained viral concentration–Ct value matching results by repeating the quantitative evaluation of the commercial reference substance 5 times. The mean Ct values of E and RdRp genes for each viral concentration were as follows: 100,000 copies/mL, 27.68 and 26.62 cycles; 10,000 copies/mL, 31.85 and 30.88 cycles; 1,000 copies/mL, 34.55 and 34.01 cycles; and 100 copies/mL, no fluorescence signal detection.

Figure 3.

Figure 3

Follow-up of the Ct value of SARS-CoV-2 RdRp gene of samples with low viral load up to 2 days at 35°C to 40°C. Bars indicate mean (SEM). Negative results (fluorescence signal not detected, not amplified by PCR) are included in the statistical calculations, calculated by substituting 40 (the maximum PCR cycle). T (36) indicates positive interpretation, target cutoff Ct ≤ 36. Ct, cycle threshold; DW: distilled water; PBS, phosphate-buffered saline; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; UTM, universal transport medium.

Discussion

As is known, viral nucleic acid detection does not necessarily mean that the host has infectivity.15-17 Unfortunately, in this study, SARS-CoV-2 infectiveness was not assessed using viral culture; however, several recent studies have reported that infectivity is extremely low 2 weeks or more after symptom onset and when the RT-qPCR Ct value is higher than 30.9,10,16,20 Nevertheless, there could be 1- or 2-cycle variations for the Ct value due to differences in the sample-collection technique, the type of nucleic acid extraction, the PCR kit, or the patient’s condition.20,21 In this research, when samples with relatively high viral load (Ct ≤ 30 cycle) from patients with high infectiveness were stored in UTM and PBS, there was no effect on the qualitative judgment (positive or negative) for up to 7 days at 2°C to 8°C, 20°C to 22°C, and even 35°C to 40°C. However, 115 kits had individual emergency use authorizations for molecular diagnostic tests for SARS-CoV-2 by the US Food and Drug Administration until July 18, 2020,22 and the Standard M nCoV kit used in this study was very sensitive, with a limit of detection of 500 copies/mL. Even if other less sensitive kits were used, a negative change would be observed during 7-day storage at 2°C to 8°C.23 Consequently, it must be considered that if other kits are used, the stability of the sample might not be maintained as well as in the current study.

This analysis, based on the quantitative reference tests at 20°C to 22°C, showed that a negative RT-qPCR result change from 1 day after storage was possible if the viral concentration was lower than 10,000 copies/mL (RdRp gene Ct > 30.88 cycles). At temperatures higher than 35°C, and even at high viral concentrations of 10,000 copies/mL or more (RdRp gene Ct ≤ 30.88 cycles), there could be a negative change from 1 day after storage. However, when stored in UTM and PBS, it was possible to detect nucleic acids for a longer period than in DW and nonbuffer states. Because the media or buffer is pH controlled, UTM and PBS ensured nucleic acid stability even at high temperatures. These results are consistent with previous studies that reported the influence of pH and temperature on the infectivity and stability of several viral nucleotides.24-30 Accordingly, we recommend that the samples should always be placed in media or buffer (eg, UTM or PBS), especially in the summer, to account for delayed shipping and refrigeration.

In this study, only RdRp PCR results were analyzed. The reason is that RdRp tends to be amplified approximately 1 cycle ahead of E on average among total positive samples, and when the viral load is lowered during treatment, the RdRp gene tends to reach negative conversion faster than the E gene. Therefore, the RT-qPCR Ct value of RdRp is more clearly separated into positive or negative than E; therefore, it is easier to analyze. If we used combined E and RdRp analysis (positive, “E and RdRp Ct ≤ 36”; negative, “E and RdRp not amplified until maximum cycle number”; and inconclusive, “neither positive nor negative”), 1 negative sample at 20°C to 22°C, 3 negative samples at 35°C to 40°C, and 1 positive sample at 35°C to 40°C would be reclassified as inconclusive. However, the overall results of combined E and RdRp analysis did not significantly differ from those of only RdRp based on the following observations. First, when stored at 2°C to 8°C, all 80 samples were positive and showed no significant Ct change for 7 days. Second, samples with low viral load showed negative changes at more than 20°C to 22°C from 1 day after storage. Third, the higher the storage temperature, the faster the nucleic acid was degraded, and viral RNA was not amplified by RT-qPCR. Fourth, the virus and nucleic acids were more stable in the pH-controlled UTM or PBS.

This study has a few limitations. Normal saline, which is commonly used as a transport medium in general laboratories, was not evaluated as a buffer. In addition, because this study was retrospective, it was not possible to perform additional experiments by changing the buffer, and the sample volumes were very small because only archived samples were used. Based on the laboratory techniques and reagent conditions, Ct values of RT-qPCR showed a slight fluctuation. Therefore, samples near the limit of detection with a low viral load (with a high Ct value) might be changed as positive or negative, and it is necessary to test them several times.20,21,31 However, the current study analyzed a limited number of samples that could be duplicated only at the point of the negative change.

Based on the findings of this study, we suggest that the detection of SARS-CoV-2 nucleic acid should be completed as soon as possible after sample collection. In addition, the storage of samples in pH-controlled media or buffer and at a low temperature, in case the molecular test is delayed, is recommended. Especially in hot weather, it is important to prepare adequate transport and refrigeration utilities. This study is expected to serve as a suitable reference for effective shipping and storage conditions to detect nucleic acids from this novel virus.

References

  • 1. Zhu N, Zhang D, Wang W, et al.  China Novel Coronavirus Investigating and Research Team A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med.  2020;382:727-733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Huang C, Wang Y, Li X, et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet.  2020;395:497-506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Gorbalenya AE, Baker SC, Baric RS, et al.  The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536-544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Sohrabi C, Alsafi Z, O’Neill N, et al.  World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg.  2020;76:71-76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. World Health Organization. WHO coronavirus disease (COVID-19) dashbord.  https://covid19.who.int/. Accessed July 18, 2020.
  • 6. Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19) https://www.cdc.gov/coronavirus/2019-ncov/index.html. Accessed July 18, 2020.
  • 7. European Centre for Disease Prevention and Control. COVID-19 pandemic https://www.ecdc.europa.eu/en/covid-19-pandemic. Accessed July 18, 2020.
  • 8. Korea Centers for Disease Control and Prevention. The COVID-19 response guidelines. 9th ed http://ncov.mohw.go.kr/upload/viewer/skin/doc.html?fn=1594339391392_20200710090312.pdf&rs=/upload/viewer/result/202008/Korean. Accessed July 18, 2020. [Google Scholar]
  • 9. La Scola B, Le Bideau M, Andreani J, et al.  Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis.  2020;39:1059-1061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Bullard J, Dust K, Funk D, et al.  Predicting infectious SARS-CoV-2 from diagnostic samples [published online ahead of print May 22, 2020]. Clin Infect Dis. 10.1093/cid/ciaa638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Kim JY, Ko J-H, Kim Y, et al.  Viral load kinetics of SARS-CoV-2 infection in first two patients in Korea. J Korean Med Sci. 2020;35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Miller JM, Binnicker MJ, Campbell S, et al.  A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis.  2018;67:e1-e94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Kim SI, Lee JY. Walk-through screening center for COVID-19: an accessible and efficient screening system in a pandemic situation. J Korean Med Sci. 2020;35:e154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Kwon KT, Ko JH, Shin H, et al.  Drive-through screening center for COVID-19: a safe and efficient screening system against massive community outbreak. J Korean Med Sci.  2020;35:e123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Kumar P. Methods for rapid virus identification and quantification. Mater Methods. 2013;3:207. [Google Scholar]
  • 16. Joynt GM, Wu WK. Understanding COVID-19: what does viral RNA load really mean?  Lancet Infect Dis.  2020;20:635-636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Chan KH, Peiris JS, Lam SY, et al.  The effects of temperature and relative humidity on the viability of the SARS coronavirus. Adv Virol.  2011;2011:734690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Wölfel R, Corman VM, Guggemos W, et al.  Virological assessment of hospitalized patients with COVID-2019. Nature.  2020;581:465-469. [DOI] [PubMed] [Google Scholar]
  • 19. Walsh KA, Jordan K, Clyne B, et al.  SARS-CoV-2 detection, viral load and infectivity over the course of an infection. J Infect.  2020;81:357-371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Espy MJ, Uhl JR, Sloan LM, et al.  Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev.  2006;19:165-256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Suliman B. Comparison of five viral nucleic acid extraction kits for the efficient extraction of viral DNA and RNA from cell-free samples. Trends Med. 2019;19:1-4. [Google Scholar]
  • 22. US Food and Drug Administration. Coronavirus disease 2019 (COVID-19) emergency use authorizations for medical devices/in vitro diagnostics EUAs https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/vitro-diagnostics-euas. Accessed July 18, 2020.
  • 23. Buchan BW, Hoff JS, Gmehlin CG, et al.  Distribution of SARS-CoV-2 PCR cycle threshold values provide practical insight into overall and target-specific sensitivity among symptomatic patients. Am J Clin Pathol.  2020;154:479-485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Druce J, Garcia K, Tran T, et al.  Evaluation of swabs, transport media, and specimen transport conditions for optimal detection of viruses by PCR. J Clin Microbiol.  2012;50:1064-1065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Liu H, Gan Y, Wu Y, et al.  Effects of different lysis buffers of nucleic acid purification kit on the stability of influenza virus RNA. Future Virol. 2014;9:549-555. [Google Scholar]
  • 26. Dauner AL, Gilliland TC, Mitra I, et al.  Evaluation of nucleic acid stabilization products for ambient temperature shipping and storage of viral RNA and antibody in a dried whole blood format. Am J Trop Med Hyg.  2015;93:46-53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Li L, Li X, Guo Z, et al.  Influence of storage conditions on SARS-CoV-2 nucleic acid detection in throat swabs. J Infect Dis.  2020;222:203-205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Di Lella S, Herrmann A, Mair CM. Modulation of the pH stability of influenza virus hemagglutinin: a host cell adaptation strategy. Biophys J.  2016;110:2293-2301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Yuan H, Li P, Ma X, et al.  The pH stability of foot-and-mouth disease virus. Virol J.  2017;14:233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Pocock DH, Garwes DJ. The influence of pH on the growth and stability of transmissible gastroenteritis virus in vitro. Arch Virol.  1975;49:239-247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Greene DN, Dickerson JA, Greninger AL, et al.  When to re-test: an examination of repeat COVID PCR patterns in an ambulatory population [published online ahead of print June 17, 2020]. J Clin Microbiol. doi:10.1128/JCM.01179-20. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Clinical Pathology are provided here courtesy of Oxford University Press

RESOURCES